Project 1. Avoidance of autoimmunity relies on carefully regulated and appropriate interplay between genetics, the environment, and components of both the innate and adaptive (acquired) immune systems;a central hypothesis to this P01. Given the innate immune system's role in monitoring the microbiologic and biochemical environments, and providing rapid protective acquired immune responses, it is well positioned to break tolerance in response to environmental signals. Dendritic Cells [DC] provide this linkage, in part, through pattern recognition receptors [e.g., toll like receptors [TLR], and retinoic acid-induced gene 1-likereceptors [RLR] that """"""""detect"""""""" bacterial/viral/biochemical and """"""""self"""""""" molecular signatures leading td DC activation and inflammation. DC activation by TLR/RLR results in Type 1 interferons [IFNa/B] that drive DC maturation, THI, antibody, and CTL responses. Project 1 poses an interdigitating hypothesis;the conjoint defects in type 1 IFN biology, hyperactive IFNa/B responses and increased plasmacytoid DC (PDC)/IFNa/B production in the islet microenvironment play a critical role in TID pathogenesis. These defects, investigated with Project 2, promote;a) loss of B cell function, b) immunogenic DC, c) pro-inflammatory macrophages [MF], d) THI responses, e) enhanced CTL and p cell killing and f) downgrading of protective Treg and iNKT cell responses. As a corollary, the defects reach full potential when PDC or other immune cells are activated by exogenous or endogenous factors that stimulate IFNa/B production, linking environment and immunogenetics. In addition, a major emphasis will be to evaluate the effect of specific candidate genotypes, (Ifihl,Tyk2) identified in genome wide association studies (GWAS) and affecting IFNa/B biology, on specific immune cell function and p cell function. We believe Project 1 finds marked significance and innovation through the integrative approach afforded by the P01 mechanism (with Project 2), and quite importantly, our ability to explore lymphoid and pancreatic tissues from the nPOD program
In sum, patients with type 1 diabetes, as well as those at risk for developing the disease, would benefit from this translational research effort. In addition. Project 1 holds the promise of providing detailed mechanistic information on disease pathogenesis of human TID, as well as novel therapeutics for preventing and/or reversing the disorder.
Showing the most recent 10 out of 117 publications
